{'fraction_non_alphanumeric': 0.023529411764705882, 'fraction_numerical': 0.011764705882352941, 'mean_word_length': 6.09375, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 2, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The Right Therapy Starts with the Right Test: Novel Therapeutic Approaches in Oncology Foster the Need for an Appropriate Molecular Profiling Strategy

Adding a molecular perspective to the traditional multidisciplinary management of cancer patients is substantially hampering the adoption of precision therapy. Indeed, at this year’s European Society for Medical Oncology (ESMO) Congress in Munich, Germany, gathering >28,000 healthcare professionals spanning a range of disciplines, fields, and stakeholder groups, and >500 invited speakers, much attention focussed on discussing how to facilitate the integration of molecular data in the clinical management of cancer patients.